Every year, thousands of experienced Medical Representatives in India consider transitioning from salaried field roles to independent Propaganda-cum-Distribution (PCD) franchise ownership. The economics are compelling: a strong MR with 3-5 years of prescriber relationships can earn 3-5x their MR salary as a PCD partner within 18 months — if the transition is structured correctly. This guide walks through every step, capital requirements, and the specific common mistakes that cause 40%+ of MR-to-PCD transitions to fail in the first year.
Why MRs Have a Built-In Advantage in PCD
Established MRs already have three of the four assets every PCD franchise needs: a defined prescriber list, working knowledge of clinical positioning, and territory familiarity. The fourth — capital and supplier relationships — is what this guide solves.
Step 1: Honest Self-Assessment Before You Resign
Before quitting your MR role, validate three things:
- Prescriber depth: List your top 50 prescribers by name. Of these, how many will continue meeting you when you carry a different brand? Realistic conversion: 30-50%.
- Working capital: Can you fund ₹5-15 Lakh inventory + ₹2-5 Lakh operating expenses for the first 6 months without external dependence? PCD businesses have 60-90 day collection cycles.
- Therapy specialisation: Critical care, derma, cardiac, gynae, paediatric — pick ONE primary therapy where you have prescriber depth, expand to second only after Year 1.
Step 2: Capital Requirements (Realistic 2026 Numbers)
Minimum viable PCD launch capital in 2026:
- Inaugural inventory order (5-10 SKUs): ₹3-6 Lakh
- Marketing materials and samples: ₹50,000-1 Lakh (often included with first order)
- Vehicle (if not already owned): ₹0-3 Lakh (used 2-wheeler workable for tier-2/3 cities)
- Drug License (Wholesale): ₹50,000-1 Lakh including consultant fees
- GST registration + accounting setup: ₹15,000-30,000
- Working capital buffer (3 months): ₹2-4 Lakh
Total realistic launch capital: ₹6-15 Lakh. Below ₹6 Lakh, you are likely undercapitalised for sustainable growth.
Step 3: Selecting the Right PCD Supplier
The supplier selection decision determines 60-70% of your eventual success or failure. Evaluate any PCD pharma supplier on:
- Regulatory compliance: WHO-GMP, ISO 9001:2015, FSSAI (for nutraceuticals), AYUSH (for herbal). Schedule C/C(1) Drug License is mandatory.
- Product range depth in your therapy: Avoid suppliers with 5-10 products in your therapy — you’ll outgrow them in 6 months. Pick suppliers with 50+ products in your target area.
- Monopoly territorial allocation: Documented in writing — your district must be exclusively yours.
- Net pricing transparency: Healthy Price-To-Retailer (PTR) and Price-To-Stockist (PTS) margins (typically 25-40% PTR markup over net rate).
- Promotional support package: Visual aids, sample packs, scientific literature, MR kits — included with first order at no extra cost.
- Replenishment lead time: 30-45 business days from PO to dispatch is industry standard.
- Multi-division flexibility: Suppliers offering multiple divisions (critical care + general + nutraceutical + herbal) enable portfolio expansion without juggling 4 different supplier relationships.
BIOFRIL HEALTHCARE Private Limited operates exactly this multi-division structure with 700+ formulations across Critical Care, General Range, Nutraceutical, and Herbal & Ayurvedic divisions. Explore our PCD franchise opportunities →
Step 4: Legal and Regulatory Setup (Parallel to Supplier Negotiation)
- Register your business: Pvt Ltd (preferred for institutional sales) or Sole Proprietorship (faster, lower compliance burden). ₹15,000-40,000.
- GST registration: Mandatory for ₹20 Lakh+ turnover. Apply on gst.gov.in. ₹0 (DIY) or ₹2,000-5,000 with CA.
- Drug License — Schedule C/C(1) Wholesale: Apply through your state Drug Controller. ₹3,000-5,000 government fee + ₹50,000 consultant fee. Time: 60-90 days.
- FSSAI (only if distributing nutraceuticals): Apply on foscos.fssai.gov.in. State License ₹2,000-5,000/year.
- Trade Mark for your trading entity name: ₹9,000 (Class 35 — distribution services).
- Bank current account + payment infrastructure: Razorpay/PayU for distributor payments.
Step 5: The First 90 Days After Launch
The first 90 days determine your viability. Focus exclusively on:
- Prescriber outreach (40-50% of time): Visit your top 50 prescribers in 45-60 days. Lead with samples, leave behind literature.
- Pharmacy stocking (25-30% of time): Get your products stocked at 30-50 pharmacies in your district. Even 5-10 units per pharmacy creates prescription fulfilment availability.
- Order processing (10-15% of time): Track each order from PO to dispatch. Build distributor confidence through reliability.
- Working capital management (5-10% of time): Track invoices, collections, and inventory turnover weekly.
Common Pitfalls That Kill 40%+ of MR-to-PCD Transitions
- Overestimating prescriber loyalty. Many MRs assume 70-80% of prescribers will follow them. Actual conversion is 30-50%. Build financial model on 30%.
- Picking the cheapest supplier. ₹2 cheaper per unit on a 5,000-unit order = ₹10,000 saving. One ICU rejection due to QC issues = ₹2-5 Lakh lost contract. Quality > price.
- Spreading too thin across therapies. Trying to be a PCD for 8 therapy areas in Year 1 = no depth in any. Pick ONE primary therapy, expand in Year 2.
- Undercapitalising working capital. 60-90 day collection cycles mean you need 4 months of working capital before first realisation. Run out, lose distributors.
- Ignoring documentation. Pharmacies and hospitals need Drug License, GST invoice format, COA copies. Sloppy paperwork = lost contracts.
Realistic Year 1, Year 2, Year 3 Projections
| Year | Monthly Sales (Realistic) | Monthly Profit (After Expenses) | Comparable MR Salary |
|---|---|---|---|
| Year 1 | ₹1.5-3 Lakh/month | ₹30,000-80,000 | ₹40,000-60,000 |
| Year 2 | ₹4-8 Lakh/month | ₹1-2.5 Lakh | ₹50,000-80,000 |
| Year 3+ | ₹10-25 Lakh/month | ₹2.5-7 Lakh | ₹60,000-1 Lakh |
Note: Year 1 PCD income often matches or slightly trails MR salary. The real returns come in Year 2-3 once supplier discounts, distributor network, and prescriber depth compound.
Next Steps
If you’re an experienced Medical Representative considering PCD transition, the highest-leverage next step is selecting the right multi-division supplier with monopoly territorial allocation and full regulatory compliance — before resigning your current role.
Submit a PCD franchise application with BIOFRIL HEALTHCARE →
Browse all four PCD division opportunities · Critical Care PCD · General Range PCD · Nutraceutical PCD